MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 265 filers reported holding MYRIAD GENETICS INC in Q4 2018. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $927,000 | +165.6% | 31,900 | +170.3% | 0.06% | +74.3% |
| Q1 2018 | $349,000 | -15.3% | 11,800 | -1.7% | 0.04% | -18.6% |
| Q4 2017 | $412,000 | -12.3% | 12,000 | -7.7% | 0.04% | -12.2% |
| Q3 2017 | $470,000 | +39.9% | 13,000 | 0.0% | 0.05% | +22.5% |
| Q2 2017 | $336,000 | +34.4% | 13,000 | 0.0% | 0.04% | +21.2% |
| Q1 2017 | $250,000 | +7.3% | 13,000 | -7.1% | 0.03% | -31.2% |
| Q4 2016 | $233,000 | -19.1% | 14,000 | 0.0% | 0.05% | -7.7% |
| Q3 2016 | $288,000 | -32.7% | 14,000 | 0.0% | 0.05% | -35.8% |
| Q2 2016 | $428,000 | -18.3% | 14,000 | 0.0% | 0.08% | -14.7% |
| Q1 2016 | $524,000 | – | 14,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |